ARTICLE | Clinical News
IMAB362: Phase II data
June 13, 2016 7:00 AM UTC
Top-line data from the open-label, European Phase II FAST trial in 161 patients with CLND18.2-positive advanced or recurrent gastric or gastroesophageal junction cancer who have not received previous ...